Differential cytotoxicity of triphala and its phenolic constituent gallic acid on human prostate cancer LNCap and normal cells

Anticancer Research

Volumn 31, Issue 11, 2011, Pages 3739-3745

  Russell Jr , Larry H ^a   Mazzio, Elizabeth ^a   Badisa, Ramesh B ^a   Zhu, Zhi Ping ^a   Agharahimi, Maryam ^a   Millington, Donna J ^b   Goodman, Carl B ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

^b VAMRC   (United States)

Author keywords

Ayurvedic medicine; Cytotoxicity; Gallic acid; Prostate cancer; Triphala

Indexed keywords

ANDROSTANOLONE; AYURVEDIC DRUG; CRYSTAL VIOLET; FLUTAMIDE; GALLIC ACID; POLYPHENOL; TRIPHALA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM;

APOPTOSIS; CELLS, CULTURED; DIHYDROTESTOSTERONE; GALLIC ACID; HUMANS; MALE; PLANT EXTRACTS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 83055179605     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
2. Kamil N, Kamil S, Ahmed SP, Ashraf R, Khurram M and Ali MO: Toxic effects of multiple anticancer drugs on skin. Pak J Pharm Sci 23: 7-14, 2010.
3. Badisa RB, Darling-Reed SF, Patrick J, Cooperwood JS, Latinwo LM and Goodman CB: Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells. Anticancer Res 29: 2993-2996, 2009.
4. Chaudhuri SK, Badisa R B, Pilarinou E and Walker EH: Licamichauxii A and B acids - Two Ent-kaurene diterpenoids from Licania michauxii. Nat Prod Lett 16: 39-45, 2002. (Pubitemid 34406470)
5. Badisa RB, Lambert AT, Ikediobi CO and Walker EH: Selective anticancer activity of pure licamichauxiioic-B acid in cultured cell lines. Pharm Biol 44: 141-145, 2006.
6. de Bono JS and Ashworth A: Translating cancer research into targeted therapeutics. Nature 467: 543-549, 2010.
7. Jagetia GC, Baliga MS, Malagi KJ and Kamath MS: The evaluation of the radioprotective effect of Triphala (an Ayurvedic rejuvenating drug) in the mice exposed to gamma-radiation. Phytomedicine 9: 99-108, 2002. (Pubitemid 34297364)
8. Sandhya T, Lathika KM, Pandey BN and Mishra KP: Potential of traditional Ayurvedic formulation, Triphala, as a novel anticancer drug. Cancer Lett 231: 206-214, 2006. (Pubitemid 43038731)
9. Sandhya T and Mishra KP: Cytotoxic response of breast cancer cell lines, MCF7 and T47D to Triphala and its modification by antioxidants. Cancer Lett 238: 304-313, 2006. (Pubitemid 43867916)
10. Kaur S, Arora S, Kaur K and Kumar S: The in vitro antimutagenic activity of Triphala - an Indian herbal drug. Food Chem Toxicol 40: 527-534, 2002. (Pubitemid 34219279)
11. Singleton VL and Rossi JA Jr.: Colorimetry of total phenolics with phosphomolybdicphosphotungstic acid reagents. Am J Enol Viticul 16: 144-153, 1965.
12. Badisa RB, Tzakou O, Couladis M and Pilarinou E: Cytotoxic activities of some Greek Labiatae herbs. Phytother Res 17: 472-476, 2003. (Pubitemid 36605896)
13. Yen GC, Duh PD and Tsai LH: Antioxidant and pro-oxidant properties of ascorbic acid and gallic acid. Food Chem 79: 307-313, 2002.
14. Naik GH, Priyadarsini KI, Bhagirathi RG, Mishra B, Mishra KP, Banavalikar MM and Mohan H: In vitro antioxidant studies and free radical reactions of Triphala, an Ayurvedic formulation and its constituents. Phytother Res 19: 582-586, 2005. (Pubitemid 41375239)
15. Pfundstein B, El Desouky SK, Hull WE, Haubner R, Erben G and Owen RW: Polyphenolic compounds in the fruits of Egyptian medicinal plants (Terminalia bellerica, Terminalia chebula and Terminalia horrid): Characterization, quantitation and determination of antioxidant capacities. Phytochemistry 71: 1132-1148, 2010.
16. Mukherjee B and Mayer D: Dihydrotestosterone interacts with EGFR/MAPK signaling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells. Int J Oncol 33: 623-629, 2008.
17. Lu Z, Nie G, Belton PS, Tang H and Zhao B: Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives. Neurochem Int 48: 263-274, 2006. (Pubitemid 43177148)
18. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA and Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818, 1983. (Pubitemid 13122588)
19. Chou TC: Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70: 440, 2010.